SMi’s 9th Annual Pharmaceutical Microbiology Conference

Copthorne Tara Hotel, London, UK (January 20-22, 2020)

SPONSORED BY: Associates of Cape Cod, bioMérieux, COPAN, METTLER TOLEDO, Microbiologics, Microgenetics, Reading Scientific Services Limited, Veltek Associates

CHAIRED BY: James Drinkwater, Chairman, Pharmaceutical and Healthcare Science Society and Olivier Chancel, Sterility and Aseptic Practices Expert, Boehringer Ingelheim

Pharmaceutical Microbiology as an industry is projected to see significant advancements in the next five years. This forecast is largely attributed to rapid microbiology testing, which has accounted for $3.5 billion last year, while projected to reach nearly double at $6 billion by 2025, and an estimated CAGR of 8.3% leading up to 2025.

At the very core of pharmaceutical microbiology is the accurate and reliable detection of microorganisms that would otherwise contaminate the pharmaceutical products manufactured. This demand for more rapid methods for detection and identification will be accompanied by equally important areas such as: contamination control strategies and environmental monitoring, process automation, and discussing updates to meet regulatory requirements.

Join us at SMi’s 9th Annual Pharmaceutical Microbiology Conference to explore novel and developing technologies that tackle the most pressing challenges and push innovation in world of pharmaceutical microbiology.

WHO SHOULD ATTEND?

Senior Microbiologist, Lead Scientist, Laboratory Manager, QA Specialist Drug Substance External Manufacturer, Business Development Manager – Testing, Pharmaceutical Microbiology Consultant, Higher Pharmacopoeia Scientist, Analytical Standards Specialist

Website: www.pharma-microbiology.com/gate2biotech